Breast Neoplasms: all 12,820 studies
Page 89 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PETCompletedNCT02850302Not applicable
- Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast CancerActive, not recruitingNCT02849496Phase 2
- Qigong For PPSP In Breast Cancer Pain In Breast Cancer SurvivorsCompletedNCT02848989Not applicable
- To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast CancerCompletedNCT02846428Phase 2
- Neurophysiological Evaluation of Training Effect on Cancer-Related WeaknessCompletedNCT02844504Not applicable
- Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerCompletedNCT02844335Phase 1/2
- Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerCompletedNCT02843126Phase 1/2
- Exercise Preconditioning and Breast Cancer CardiotoxicityCompletedNCT02842658Not applicable
- Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast CancerStatus unknownNCT02842099Phase 2
- Osteopathy and Prevention of Gastrointestinal Side Effects in Women Treated for Breast CancerCompletedNCT02840890Not applicable
- Couples-Based Mindfulness for Young Breast Cancer SurvivorsCompletedNCT02840344Not applicable
- CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorStatus unknownNCT02839954Phase 1/2
- The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC)CompletedNCT02839668Phase 2
- Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized TrialCompletedNCT02839473Phase 3
- Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Patients With Advanced Breast CancerCompletedNCT02838823Phase 1
- X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast CancerStatus unknownNCT02838238Phase 2
- DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast CancerCompletedNCT02838225Phase 2
- Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation TreatmentCompletedNCT02836093
- Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), NEOELASTOCompletedNCT02834494Not applicable
- Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast CancerTerminatedNCT02833766Phase 2
- Entinostat in Chinese Postmenopausal Women Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT02833155Phase 1
- A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope)CompletedNCT02831634Not applicable
- Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast CancerCompletedNCT02831582Not applicable
- Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer PatientsCompletedNCT02831530Phase 2
- A Statewide Intervention to Reduce Use of Unproven or Ineffective Breast Cancer CareCompletedNCT02831439Not applicable
- Pre-pectoral Breast Reconstruction PART 1Status unknownNCT02830685Phase 3
- Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast CancerCompletedNCT02830282
- Dynamic Infrared Thermography in Breast Cancer DiagnosticsCompletedNCT02829021Not applicable
- Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer PatientsStatus unknownNCT02829008Phase 2
- Therapeutic Exercise in Cancer-Related Fatigue in Women After Breast Cancer TreatmentCompletedNCT02828189Not applicable
- CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast CancerCompletedNCT02827370Not applicable
- A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer PatientsTerminatedNCT02826512Phase 2
- Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast CancerActive, not recruitingNCT02826434Phase 1
- Cervical Motor Control in Long-term Breast Cancer SurvivorsWithdrawnNCT02825810Not applicable
- Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast CancerTerminatedNCT02824575Phase 1
- A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURECompletedNCT02824484Not applicable
- A Breast Cancer Treatment Decision Aid for Women Aged 70 and OlderTerminatedNCT02823262Not applicable
- Acute Pain Trajectories and Persistent Pain After Breast Cancer SurgeryCompletedNCT02823015
- Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast CancerCompletedNCT02820961Phase 1
- Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking TamoxifenTerminatedNCT02819921Phase 4
- Integral Strategy to Supportive Care in Breast Cancer PatientsStatus unknownNCT02817724Not applicable
- A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast CancerStatus unknownNCT02817334Phase 2
- A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile NeutropeniaCompletedNCT02816164Phase 4
- Effects of Omega-3 Fatty Acids on Risk Factors for Breast Cancer in Pre-menopausal WomenCompletedNCT02816125Phase 3
- RETROSPECTIVE ANALYSIS OF BREAST BIOPSIES IN WOMEN YOUNGER THAN 40 YEARS OLDCompletedNCT02815852
- Optimizing the Care Pathways of Patients Treated for Operable Breast.CompletedNCT02813317
- Retrospective Analysis of Effectiveness and Safety Profile of Anastrozole and Letrozole in HR+ Breast Cancer PatientsStatus unknownNCT02812277
- Substantially Improving the Cure Rate of High-risk BRCA1-like Breast CancerActive, not recruitingNCT02810743Phase 3
- Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data AnalysisStatus unknownNCT02810093
- Antibiotic Prophylaxis in Oncological Surgery of BreastCompletedNCT02809729Not applicable
- Breast Cancer Trials Education ProgramCompletedNCT02808598Not applicable
- ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial MetabolismCompletedNCT02806817Early Phase 1
- Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy AloneTerminatedNCT02806258Phase 1/2
- PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent NeutropeniaCompletedNCT02805205Phase 4
- PEG-rhG-CSF in Patients With Breast Cancer Receiving ChemotherapyCompletedNCT02805153Phase 4
- Combined Training on Body Composition of Postmenopausal Women Undergoing Treatment for Breast CancerCompletedNCT02804308Not applicable
- Effectiveness of Acupuncture for Breast Cancer Related LymphedemaStatus unknownNCT02803736Not applicable
- Studying Tailored Exercise Prescriptions in Breast Cancer PatientsStatus unknownNCT02802826Phase 3
- Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)CompletedNCT02802748Early Phase 1
- Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled LesionsActive, not recruitingNCT02802553Not applicable
- Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast CancerCompletedNCT02802098Early Phase 1
- RISAS Procedure in Node Positive Breast Cancer Following NACCompletedNCT02800317Not applicable
- Brazilian Randomized Study - Impact of MRI for Breast CancerCompletedNCT02798796Not applicable
- Evaluation of the High-resolution, Contrast Enhanced Low-dose Breast-CTStatus unknownNCT02798562Not applicable
- Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance ImagingCompletedNCT02798484Not applicable
- The Breast Program - Translational Cancer ResourceActive, not recruitingNCT02798341
- Clinical Application of CTDNA in Operable Breast Cancer PatientsStatus unknownNCT02797652
- Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer TherapyTerminatedNCT02795572Phase 2
- Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast CarcinomasCompletedNCT02794558Not applicable
- A Prototype Tri-modal Imaging Device for Breast CancerCompletedNCT02794064Phase 1
- Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerApproved for marketingNCT02792725
- A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid TumorsCompletedNCT02792465Phase 1
- T-Cell Therapy for Advanced Breast CancerActive, not recruitingNCT02792114Phase 1
- 5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive CarcinomaCompletedNCT02791750
- Understanding and Predicting Breast Cancer Events After TreatmentActive, not recruitingNCT02791581Not applicable
- Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer PatientsStatus unknownNCT02790580Phase 2
- Eribulin [Halaven] Use For the Treatment of Advanced Breast CancerCompletedNCT02790320
- Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination DeficiencyCompletedNCT02789332Phase 2
- ICAN Symptoms Duke-NUSCompletedNCT02787993Not applicable
- Diet, Exercise and Vitamin D in Breast Cancer RecurrenceStatus unknownNCT02786875Phase 3
- Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer SurvivorsCompletedNCT02786797Not applicable
- Step by Step After CancerCompletedNCT02785861Not applicable
- Iterative PICC Placement Versus Long Term DeviceWithdrawnNCT02784730Phase 3
- BP-C1 in Short-term Treatment of Patients With Metastatic Breast CancerCompletedNCT02783794Phase 2
- Evaluating the Effects of Genetic Testing on Patients' Stress LevelsActive, not recruitingNCT02783664
- EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT CancerCompletedNCT02783222Phase 2
- Pilot Study of Bisphosphonates for Breast CancerTerminatedNCT02781805Phase 1
- Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast CancerStatus unknownNCT02781259Phase 4
- Limiting Chemotherapy Side Effects by Using MoxaStatus unknownNCT02781155Phase 1/2
- Risk Assessment Tool in Saudi ArabiaStatus unknownNCT02781116
- Diet and Physical Activity Changes Among Latina Breast Cancer SurvivorsCompletedNCT02780271Not applicable
- A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast CancerActive, not recruitingNCT02779751Phase 1
- Study on Efficacy and Safety of CBLB612 for Neutropenia ProphylaxisCompletedNCT02778763Phase 2
- Evaluation of a 3D Functional Metabolic Imaging and Risk Assessment System for Classifying Women at High Risk of Breast CancerTerminatedNCT02777164Not applicable
- Reducing Dexamethasone Around Docetaxel InfusionCompletedNCT02776436Phase 1
- Outcome of Pregnancy and Breast CancerStatus unknownNCT02774915
- Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.CompletedNCT02773784
- Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast CancerCompletedNCT02773004Not applicable
- Shave Margins vs. Standard Partial Mastectomy in Breast Cancer PatientsCompletedNCT02772731Not applicable
- Primary Radiotherapy And DIEP flAp Reconstruction TrialCompletedNCT02771938Not applicable